ICRP’s mission is to improve access to information about global cancer research funding, and enable cancer research funding organizations to work collaboratively to address common challenges. Our annual meetings are a great opportunity to connect with other cancer research funders, identify gaps in funding, explore options for collaborative funding and exchange innovative ideas. A summary of the 2019 Annual meeting can be found here and please visit our library to view summaries of our previous meetings.
Due to the COVID-19 pandemic, our annual in-person meetings in 2020 and 2021 have been suspended.
2021 ICRP Free Virtual Meeting series
Addressing disparities in international cancer research (22 March 2021 at 14.00 GMT)
- Chair: Professor Richard Sullivan, King's College London, UK
- Speaker(s): Sigourney Bell, BSc (Co-founder, Blackincancer), Aisha Lofters MD, PhD CCFP (Peter Gilgan Centre for Women’s Cancers, Women’s College Hospital, Toronto, Canada), Geetanjali Datta ScD, MPH (Cedars-Sinai Cancer Research Center for Health Equity, USA)
- About the session: this session focuses on highlighting disparities in cancer research funding and identifying best practice for international funders in addressing disparities. The panel will discuss global cancer inequalities, mentoring black cancer researchers and promoting community cancer awareness, patient-centred approaches to removing barriers to participation in cancer screening and prevention, and transforming race-based cancer research.
- Who should attend?
Representatives cancer research organizations worldwide are welcomed, along with anyone with an interest in the coordination of international cancer research.
- Childhood cancer (19 April 2021)
- Chair: Dr Ian Lewis, NCRI, UK
- Speaker(s): Cancer Australia, Cancer Research UK, Melanoma Research Alliance, US National Cancer Institute Center for Global Health, World Cancer Research Fund International, Worldwide Cancer Research.
This session, jointly organized with the UK’s National Cancer Research Institute, focussed on the benefits of collaboration between international cancer research funders, the impact that COVID-19 has had on funding, and opportunities for future collaborations. Delegates heard from a selection of organisations who have set up successful international collaborative funding opportunities to address gaps in cancer research, and also learn about best practice in establishing international collaborative funding streams.
If you have any questions, or want to be included on the mailing list, please contact us.
|Summary of annual meeting"|